Le Lézard
Classified in: Health, Covid-19 virus
Subjects: AWD, CHI, SVY

Dr. Peter Hotez Named To TIME's Inaugural TIME100 Health List of the 100 Most Influential People in Global Health this Year


HOUSTON, May 2, 2024 /PRNewswire/ -- Texas Children's Hospital is pleased to announce that today, TIME named Dr. Peter Hotez, co-director of the Texas Children's Hospital Center for Vaccine Development, Texas Children's Hospital endowed chair in Tropical Pediatrics and professor and dean of the National School of Tropical Medicine at Baylor College of Medicine, to the inaugural 2024 TIME100 Health, a new annual list of 100 individuals who most influenced global health this year. The full list and related tributes appear in the May 13, 2024 issue of TIME, available on newsstands on Friday, May 3, and now at time.com/time100health

"I'm grateful for the TIME100 Health 2024 recognition, particularly for our low-cost vaccines for neglected diseases and global health, as well as my efforts to counter rising antivaccine and antiscience activism," said Dr. Hotez.

The list recognizes the impact, innovation, and achievement of the world's most influential individuals in health. 

Dr. Hotez and team members from the Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine are at the forefront of vaccine development for neglected diseases. During the COVID-19 pandemic, they developed a low-cost, protein-based COVID-19 vaccine technology that is now locally produced in both India and Indonesia as Corbevax and Indovac respectively, with millions of doses administered.

Last year, Dr. Hotez received the AAAS Scientific Freedom and Responsibility Award, for promoting vaccines and combating vaccine misinformation and the IDSA's Fauci Award Courage in Leadership Award for his efforts to uphold and speak to scientific truths. He and additional members from the Texas Children's Hospital Center for Vaccine Development were awarded the 2023 David and Beatrix Hamburg Award from the National Academy of Medicine. In 2022, Dr. Hotez and Dr. Maria Elena Bottazzi, co-director of the Texas Children's Hospital and senior associate dean of the National School of Tropical Medicine at Baylor College of Medicine, were nominated for the Nobel Peace Prize for their vaccine development efforts. Dr. Hotez also received the AMA's Scientific Achievement Award. Dr. Hotez is an elected member of the National Academy of Medicine and American Academy of Arts and Sciences and the author of several books.

Follow @TIME for updates about the list on Twitter and Instagram and at Facebook.com/TIME.

#TIME100HEALTH

ABOUT TEXAS CHILDREN'S HOSPITAL 
Texas Children's, a nonprofit health care organization, is committed to creating a healthier future for children and women throughout the global community by leading in patient care, education and research. Consistently ranked as the best children's hospital in Texas and among the top in the nation, Texas Children's has garnered widespread recognition for its expertise and breakthroughs in pediatric and women's health. The system includes the Texas Children's Duncan NRI; the Feigin Tower for pediatric research; Texas Children's Pavilion for Women, a comprehensive obstetrics/gynecology facility focusing on high-risk births; Texas Children's Hospital West Campus, a community hospital in suburban West Houston; Texas Children's Hospital The Woodlands, the first hospital devoted to children's care for communities north of Houston and Texas Children's Hospital North Austin, the new state-of-the-art facility providing world-class pediatric and maternal care to Austin families. The organization also created Texas Children's Health Plan, the nation's first HMO focused on children; Texas Children's Pediatrics, the largest pediatric primary care network in the country; Texas Children's Urgent Care clinics that specialize in after-hours care tailored specifically for children; and a global health program that is channeling care to children and women all over the world. Texas Children's Hospital is affiliated with Baylor College of Medicine. For more information, visit www.texaschildrens.org. 

ABOUT TEXAS CHILDREN'S HOSPITAL CENTER FOR VACCINE DEVELOPMENT
Texas Children's Hospital Center for Vaccine Development is one of the leading vaccine development centers in the world. Established in Washington DC as the Sabin Vaccine Institute Product Development Partnership (PDP) in the year 2000 and after relocating to the Texas Medical Center in 2011, it rebranded as Texas Children's Center for Vaccine Development. For the past two decades it has acquired an international reputation as a non-profit PDP, advancing vaccines for poverty-related neglected tropical diseases (NTDs) and emerging infectious diseases of pandemic importance. In addition, it builds and strengthens capacity for vaccine development locally and with foreign nations and leads global efforts to guide and influence vaccine policy and advocacy through "vaccine diplomacy" as an international bridge for peace and vaccine development capacity.

SOURCE Texas Children's Hospital


These press releases may also interest you

at 03:58
Allied Market Research published a report, titled, "Forex Brokers Market by Counterparty (Reporting Dealers, Financial Institutions, and Non-financial Customers) and Type (Currency Swap, Outright Forward &...

at 03:45
Phoenix Motor Inc. , a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced it will host a conference call on Thursday, May 23, 2024 at 4:30 p.m. ET to discuss and answer...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Whitman-Walker Institute, which leverages research, policy, and education to advance health equity nationwide, says it's standing by to further inform the chair of the U.S. House Committee on Education and the Workforce and others about the strong...

16 mai 2024
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRAtm (tarlatamab-dlle) for the...

16 mai 2024
Swiss Water Decaffeinated Coffee Inc. ("Swiss Water" or "the Company") is pleased to announce the following voting results of the Company's Annual General Meeting of Shareholders, which was held on Thursday, May 16, 2024. Election of...



News published on and distributed by: